BioSerenity Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 270

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 11

BioSerenity General Information

Description

Developer of electrophysiology diagnostic systems designed to diagnose neurological, sleep, and cardiac disorders. The company develops connected medical devices featuring EEG systems and wearable sensors, along with an AI-powered software platform for EEG analysis, seizure detection, and clinical decision support, enabling healthcare providers to perform accurate and remote diagnostics.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 6/8 Rue Jean Antoine de Baïf
  • 75013 Paris
  • France
+33 01
Primary Industry
Diagnostic Equipment
Other Industries
Monitoring Equipment
Other Healthcare Technology Systems
Corporate Office
  • 6/8 Rue Jean Antoine de Baïf
  • 75013 Paris
  • France
+33 01

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioSerenity Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
13. Secondary Transaction - Private 01-May-2026 Completed Generating Revenue
12. Accelerator/Incubator Completed Generating Revenue
11. Accelerator/Incubator Completed Generating Revenue
10. Later Stage VC 13-Nov-2023 Completed Generating Revenue
9. Accelerator/Incubator Completed Generating Revenue
8. Later Stage VC 05-Nov-2019 Completed Generating Revenue
7. Later Stage VC (Series B) 18-Jun-2019 Completed Generating Revenue
6. Early Stage VC (Series A) 20-Sep-2017 Completed Startup
5. Early Stage VC 29-Jun-2016 $3.35M Completed Startup
4. Accelerator/Incubator $3.35M Completed Startup
To view BioSerenity’s complete valuation and funding history, request access »

BioSerenity Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Shares
B Shares
B Shares
B Shares
B Shares 13,446 $1.122006 $166.89 $166.89 1x $166.89 2.37%
A Shares 66,936 $1.122006 $50.29 $50.29 1x $50.29 11.79%
To view BioSerenity’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

BioSerenity Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of electrophysiology diagnostic systems designed to diagnose neurological, sleep, and cardiac disorders. The c
Diagnostic Equipment
Paris, France
270 As of 2026

Mountain View, CA

Mountain View, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BioSerenity Competitors (25)

One of BioSerenity’s 25 competitors is NeuroVigil, a Venture Capital-Backed company based in Mountain View, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroVigil Venture Capital-Backed Mountain View, CA
AliveCor Venture Capital-Backed Mountain View, CA
Agatsa Venture Capital-Backed Noida, India
CloudTag Formerly PE-Backed Kingstown, Saint Vincent
Tricog Health Venture Capital-Backed Bengaluru, India
You’re viewing 5 of 25 competitors. Get the full list »

BioSerenity Patents

BioSerenity Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4759234-A1 Device for generating a pretrained foundation model, device for obtaining a representation of an input eeg segment and related methods Pending 10-Mar-2025
WO-2026190121-A1 Device for generating a pretrained foundation model, device for obtaining a representation of an input eeg segment and related methods Pending 10-Mar-2025
EP-4751645-A1 Preamplifier for biosignal recorder Pending 28-Nov-2024
WO-2026114534-A1 Preamplifier for biosignal recorder Pending 28-Nov-2024
US-20220409048-A1 Systems, methods, and apparatuses for detecting and quantifying biological fluids Inactive 23-Jun-2021 A61B5/0537
To view BioSerenity’s complete patent history, request access »

BioSerenity Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioSerenity Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Jolt Capital Growth/Expansion Minority
SCOR Global Life Americas Corporation Minority
Dassault Systemes Corporation Minority
Eurazeo PME PE/Buyout Minority
SCOR Ventures Corporate Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

BioSerenity Investments & Acquisitions (2)

BioSerenity’s most recent deal was a Later Stage VC with BOYDSense for . The deal was made on 05-Apr-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
BOYDSense 05-Apr-2024 Later Stage VC Monitoring Equipment
SleepMed 08-Jun-2019 Merger/Acquisition Laboratory Services (Healthcare)
To view BioSerenity’s complete investments and acquisitions history, request access »

BioSerenity FAQs

  • When was BioSerenity founded?

    BioSerenity was founded in 2013.

  • Where is BioSerenity headquartered?

    BioSerenity is headquartered in Paris, France.

  • What is the size of BioSerenity?

    BioSerenity has 270 total employees.

  • What industry is BioSerenity in?

    BioSerenity’s primary industry is Diagnostic Equipment.

  • Is BioSerenity a private or public company?

    BioSerenity is a Private company.

  • What is BioSerenity’s current revenue?

    The current revenue for BioSerenity is .

  • How much funding has BioSerenity raised over time?

    BioSerenity has raised $118M.

  • Who are BioSerenity’s investors?

    Jolt Capital, SCOR Global Life Americas, Dassault Systemes, Eurazeo PME, and SCOR Ventures are 5 of 11 investors who have invested in BioSerenity.

  • Who are BioSerenity’s competitors?

    NeuroVigil, AliveCor, Agatsa, CloudTag, and Tricog Health are some of the 25 competitors of BioSerenity.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process